Align Technology Awards $300,000 in Research Grants to Universities Worldwide to Advance Orthodontic and Dental Innovation Align Technology, Inc. a global leader in digital orthodontics and restorative dentistry, has announced the recipients of its fifteenth Annual Research Award Program, awarding…
Paw Prosper Expands Scholarship Program to Strengthen Veterinary Education and Professional Development Paw Prosper has announced a significant expansion of its scholarship program, doubling the number of awards available to veterinary students and animal care professionals pursuing continuing education. The…
Integrated DNA Technologies and Illumina Collaborate to Deliver End-to-End Oncology Research Workflows for Faster Genomic Insights Integrated DNA Technologies (IDT), a global leader in genomics and a Danaher company, has announced a strategic collaboration with Illumina aimed at simplifying and…
C2N Diagnostics and SouthGenetics Expand Access to Alzheimer’s Blood Testing Across Latin America and the Caribbean C2N Diagnostics has announced a strategic collaboration with SouthGenetics aimed at expanding access to advanced blood-based testing for Alzheimer’s disease across Latin America and…
Ontario Communities Raise Flags to Shine a Light on Brain Injury Awareness Month For one Ontario family, a tragic accident changed the course of their lives forever. When their two-year-old son was struck by a vehicle, he suffered a severe…
Eccogene and AstraZeneca to Present New Clinical Data on Elecoglipron at ADA 2026 Scientific Sessions Clinical-stage biopharmaceutical company Eccogene has announced that new clinical findings for elecoglipron (AZD5004/ECC5004), its investigational oral GLP-1 receptor agonist, will be featured at the 2026…
Sermo Survey Reveals Widespread Use of Unregulated Peptides Among Patients as Physicians Call for Greater Regulatory Clarity As healthcare providers navigate a rapidly evolving landscape of metabolic and wellness therapies, a new survey from Sermo highlights growing concerns among physicians…
NeuroPace Showcases Expanding Role of Responsive Neuromodulation at ASSFN 2026 NeuroPace, a leading medical device company dedicated to improving outcomes for people living with epilepsy, is set to play a prominent role at the 2026 American Society for Stereotactic and…
Tempus Unveils Early Results from Multimodal Foundation Models, Demonstrating Potential to Accelerate Precision Oncology and Drug Development Tempus a technology company focused on advancing precision medicine through artificial intelligence, has announced new findings from its multimodal foundation model research at…
Beren Therapeutics to Present Six Posters Highlighting Clinical and Preclinical Progress of Adrabetadex at 2026 APMRF Conference Beren Therapeutics P.B.C., the parent company of Mandos LLC and a company focused on advancing cholesterol trafficking biology and cyclodextrin-based therapeutics, has announced…
Landmark OPTIMA Trial Demonstrates Veracyte’s Prosigna Test Can Safely Reduce Chemotherapy Use in High-Risk Breast Cancer Patients Veracyte has announced groundbreaking results from the OPTIMA (Optimal Personalised Treatment of Early Breast Cancer Using Multi-parameter Analysis) trial, a large independent Phase…
Corcept Highlights New ROSELLA Data at ASCO 2026 Demonstrating Broad Survival Benefits of Lifyorli in Platinum-Resistant Ovarian Cancer Corcept Therapeutics has unveiled new findings from its pivotal Phase 3 ROSELLA clinical trial at the 2026 American Society of Clinical Oncology…